Evidence map›Paper›PMID 28656209›Full record

ArticleMolecular medicine reports2017

Hydrogen sulfide reduced renal tissue fibrosis by regulating autophagy in diabetic rats.

Lin Li, Ting Xiao, Fang Li, Yan Li, Ou Zeng, Maojun Liu, Biao Liang, Zining Li, Chun Chu, Jun Yang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Recent Advances in Molecular Research on Hydrogen Sulfide (HInternational journal of molecular sciences · 2022
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Diabetic Nephropathy and Gaseous Modulators.Antioxidants (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. HExperimental and therapeutic medicine · 2019
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lin LiDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Ting XiaoDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Fang LiDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Yan LiDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Ou ZengDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Maojun LiuDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Biao LiangDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Zining LiDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Chun ChuDepartment of Pharmacy, The Second Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
Jun YangDepartment of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.
First Affiliated Hospital of University of South China · CNUniversity of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to explore the effect of hydrogen sulfide (H2S) on renal tissue fibrosis and its mechanism in diabetic rats. Rats were randomly divided into four groups (n=13/group): Control group; induced diabetes mellitus group (STZ); induced diabetes mellitus treated with H2S group (STZ + H2S); normal rats treated with H2S group (H2S). The diabetic model was induced by intraperitoneal (i.p.) injections of 40 mg/kg body weight streptozotocin (STZ); the control group was treated with saline every day (i.p); NaHS (100 µmol/kg i.p.) was administered to rats of STZ + H2S group and H2S group. After 8 weeks, rat body weight and 24 h proteinuria levels were determined in each group, renal pathological morphology was analyzed by Masson's trichrome staining, collagen IV content was detected by immunohistochemistry, and periodic acid‑Schiff (PAS) staining was performed on renal glomerular and tubular basement membranes. The expression levels of matrix metalloproteinase 9 (MMP9), MMP7, tissue inhibitor of metalloproteinase 1 (TIMP1), superoxide dismutase (SOD), serine/threonine kinase AKT, transforming growth factor (TGF)‑β1, nuclear factor (NF)‑κB and several autophagy related proteins were assessed by western blot analysis. Compared with the control group, renal tissue fibrosis was observed, collagen IV expression and the 24 h proteinuria quantity was markedly increased and the amount of PAS positive material in renal glomerular and tubular basement membranes was notably increased in STZ‑treated rats. Furthermore, the expression levels of MMP9, MMP7, TIMP1, autophagy‑associated proteins, AKT, TGF‑β1 and NF‑κB protein were significantly increased, and SOD expression levels were significantly decreased in the STZ group compared with the control (P<0.05). In the H2S+STZ group, renal tissue fibrosis and the expression of collagen IV were improved, 24 h proteinuria was decreased, the amount of PAS positive material in renal glomerular and tubular basement membranes was decreased, the expression levels MMP9, MMP7, TIMP1, autophagy‑associated proteins, AKT, TGF‑β1 and NF‑κB protein were significantly decreased, and the expression levels of SOD were significantly increased compared with the STZ group (P<0.05). In conclusion, H2S may improve renal tissue fibrosis by inhibiting autophagy, upregulating SOD and downregulating AKT, TGF‑β1 and NF-κB.

Indexed as

AnimalsAutophagyAutophagy-Related ProteinsCollagen Type IVDiabetes Mellitus, ExperimentalFibrosisHydrogen SulfideImmunohistochemistryKidney DiseasesMaleMatrix Metalloproteinase 7Matrix Metalloproteinase 9Microtubule-Associated ProteinsNF-kappa BProteinuriaProto-Oncogene Proteins c-aktAnxa3 protein, ratAutophagy-Related ProteinsCollagen Type IVHydrogen SulfideMatrix Metalloproteinase 7Matrix Metalloproteinase 9Microtubule-Associated ProteinsMmp9 protein, ratNF-kappa BProto-Oncogene Proteins c-aktsodium bisulfideSulfidesSuperoxide DismutaseTIMP1 protein, ratTissue Inhibitor of Metalloproteinase-1Transforming Growth Factor beta1

Identifiers

PMID28656209
PMCPMC5561787
OpenAlexW2700511465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.